Site Selection involves performing Site Selection visits to sponsor or CRO SOPs to assess site suitability.
For multi-centre studies, the selection and proper evaluation of investigator sites is critical for the successful completion of a trial within budget, timelines and to ensure the generation of good quality data.
Clinical Trial feasibility is a process of evaluating the possibility of conducting a particular clinical program/trial in a particular geographical region with the overall objective of optimum project completion in terms of timelines, targets and cost.
Site ID involves contacting sites to engage directly with them and establish whether the study would be of interest to them. Site lists may already be in place for a country, based on feedback from feasibility or the sponsor directly.
We can help send out and track Confidentiality Agreements, Protocol synopses and Site Questionnaires; as well as follow up to help identify sites that may be suitable for a Site Selection visit.